Specific to B-cell lymphomas, as we have previously described in Gallardo et al., hnRNP K is overexpressed in human patients with diffuse large B-cell lymphoma and is associated with poor clinical outcomes and non-responsiveness to chemotherapy (39). This evidence concerns the gene HNRNPK and diffuse large B-cell lymphoma.